We are live on ! Find out more
CFO

Callan Family Office Portfolio holdings

AUM $4.41B
1-Year Est. Return 26.21%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
+26.21%
3 Year Est. Return
+68.96%
5 Year Est. Return
10 Year Est. Return
AUM
$1.33B
AUM Growth
-$239M
Cap. Flow
-$202M
Cap. Flow %
-15.12%
Top 10 Hldgs %
30.52%
Holding
657
New
30
Increased
136
Reduced
341
Closed
114

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$20M
2
AAPL icon
Apple
AAPL
+$19.1M
3
NVDA icon
NVIDIA
NVDA
+$18.1M
4
AMZN icon
Amazon
AMZN
+$14.7M
5
COST icon
Costco
COST
+$8.84M

Sector Composition

Rank Sector Weight
1 Technology 17.08%
2 Financials 12.66%
3 Healthcare 9.69%
4 Communication Services 6.06%
5 Consumer Discretionary 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
101
Goldman Sachs
GS
$303B
$2.96M 0.22%
5,415
-3,481
-39% -$2.09M
NVS icon
102
Novartis
NVS
$297B
$2.91M 0.22%
26,099
-2,775
-10% -$295K
TMUS icon
103
T-Mobile US
TMUS
$190B
$2.89M 0.22%
10,842
-2,131
-16% -$525K
COF icon
104
Capital One
COF
$134B
$2.89M 0.22%
16,113
-7,556
-32% -$1.43M
REET icon
105
iShares Global REIT ETF
REET
$5.11B
$2.81M 0.21%
115,942
-3,090
-3% -$75.2K
DFS
106
DELISTED
Discover Financial Services
DFS
$2.79M 0.21%
16,316
-250
-2% -$45.7K
VNQ icon
107
Vanguard Real Estate ETF
VNQ
$39.1B
$2.77M 0.21%
30,580
-30
-0.1% -$2.72K
TXN icon
108
Texas Instruments
TXN
$261B
$2.73M 0.21%
15,214
-1,002
-6% -$188K
VRTX icon
109
Vertex Pharmaceuticals
VRTX
$126B
$2.67M 0.2%
5,517
+3,067
+125% +$1.43M
GSK icon
110
GSK
GSK
$106B
$2.59M 0.19%
66,791
+9,079
+16% +$332K
OXY icon
111
Occidental Petroleum
OXY
$55.9B
$2.49M 0.19%
50,413
+10,625
+27% +$519K
BCS icon
112
Barclays
BCS
$94.1B
$2.48M 0.19%
161,731
-6,467
-4% -$96.8K
VST icon
113
Vistra
VST
$47.4B
$2.46M 0.18%
20,944
-12,832
-38% -$1.92M
STT icon
114
State Street
STT
$50.7B
$2.45M 0.18%
27,406
+16,172
+144% +$1.54M
BHP icon
115
BHP
BHP
$230B
$2.38M 0.18%
49,061
-4,415
-8% -$220K
NVO
116
Novo Nordisk
NVO
$209B
$2.32M 0.17%
33,475
+3,192
+11% +$264K
ACWI icon
117
iShares MSCI ACWI ETF
ACWI
$33.4B
$2.3M 0.17%
19,770
-5,105
-21% -$612K
CHTR icon
118
Charter Communications
CHTR
$18.2B
$2.29M 0.17%
6,218
+790
+15% +$283K
CRWD icon
119
CrowdStrike
CRWD
$218B
$2.23M 0.17%
25,332
-1,864
-7% -$178K
AZO icon
120
AutoZone
AZO
$51.1B
$2.18M 0.16%
571
-202
-26% -$697K
CVS icon
121
CVS Health
CVS
$122B
$2.17M 0.16%
32,055
+11,890
+59% +$712K
HLN icon
122
Haleon
HLN
$44.2B
$2.15M 0.16%
208,813
+2,314
+1% +$22.8K
MCD icon
123
McDonald's
MCD
$195B
$2.14M 0.16%
6,849
-3,253
-32% -$973K
DIS icon
124
Walt Disney
DIS
$181B
$2.09M 0.16%
21,218
-8,501
-29% -$914K
ZBH icon
125
Zimmer Biomet
ZBH
$18.4B
$2.06M 0.15%
18,163
+7,252
+66% +$776K

Similar funds

Callan Family Office's Q1 2025 Portfolio in Review

As of Q1 2025, Callan Family Office held 657 positions worth $1.33B, down 15% from $1.57B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Callan Family Office withdrew a net $202M in Q1 2025, closing 114 positions and reducing 341 holdings. Its most notable exit was iShares MSCI ACWI ex US ETF, an estimated $3.63M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Callan Family Office opened a new position in Berkshire Hathaway Class A worth $4.79M.

  • Callan Family Office's largest Q1 2025 buy was Berkshire Hathaway Class A: 6 shares worth $4.79M.
  • Callan Family Office added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $5.25M increase.
  • Callan Family Office's biggest Q1 2025 reduction was Microsoft, cutting an estimated $20M.
  • Callan Family Office fully exited iShares MSCI ACWI ex US ETF in Q1 2025, selling an estimated $3.63M.
  • Callan Family Office's ten largest holdings make up 31% of its $1.33B portfolio in Q1 2025.
  • Callan Family Office opened 30 new positions and closed 114 in Q1 2025.
  • Callan Family Office's portfolio value fell 15% quarter-over-quarter to $1.33B.

Based on Callan Family Office's 13F filing for Q1 2025, filed 13 May 2025.